Measured-to-predicted creatinine generation ratio increases with time and decline in residual renal function in continuous ambulatory peritoneal dialysis
Cc. Szeto et al., Measured-to-predicted creatinine generation ratio increases with time and decline in residual renal function in continuous ambulatory peritoneal dialysis, AM J KIDNEY, 34(2), 1999, pp. 235-241
The expression of measured-to-predicted creatinine generation ratio (MIP) h
as been proposed as an index of compliance in continuous ambulatory periton
eal dialysis (CAPD) patients. Although M/P may not be sensitive enough for
cross-sectional study, serial monitoring has been suggested to identify non
compliance. We attempted to evaluate serial changes of M/P from a nonselect
ed group of CAPD patients, Sixty-three patients, all followed up for 2 year
s, were reviewed retrospectively. Their MIP ratios at years 0 and 2 were co
mputed and compared, Baseline MIP had a normal distribution with a mean of
0.96 +/- 0.26. There was significant correlation between baseline MIP and r
esidual glomerular filtration rate (GFR; r = -0.81; P < 0.0001). There were
weak correlations between M/P and duration of dialysis (r = 0.52; P < 0.00
01), body weight (r = -0.52; P < 0.0001), KW (r = 0.31; P < 0.02), weekly c
reatinine clearance normalized to body surface area (r = 0.53; P < 0.0001),
and serum albumin level (r = -0.28; P < 0.05), After 2 years, M/P increase
d in 56 of 63 patients (88.9%). Average M/P increased from 0.96 +/- 0.26 to
1.31 +/- 0.27 (P < 0.0001). Multivariant analysis showed MIP at year 0, wh
ich was largely determined by residual GFR, was the only independent factor
affecting increase in M/P from year 0 to year 2. The general trend of incr
easing M/P was still present when only anuric patients were analyzed, altho
ugh that was not statistically significant (1.21 +/- 0.14 to 1.32 +/- 0.24;
P = 0.12). The finding of increasing M/P with time in CARD patients, parti
cularly those with significant residual renal function, suggests MIP may no
t be a reliable indicator of noncompliance, even for serial follow-up of th
e same patient. Better methods for assessment of compliance in CAPD patient
s are required. (C) 1999 by the National Kidney Foundation, Inc.